Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
BTAIQ holding history
BioXcel Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −4,869−100.0% | Sold outConverted for a 1-for-16 split | Holders |
| Q4 2024 | 77,900 | $29.1K | <0.1% | −51,969−40.0% | Reduced | Holders |
| Q3 2024 | 129,869 | $79.2K | <0.1% | +129,869 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −23,707−100.0% | Sold out | Holders |
| Q1 2024 | 23,707 | $67.0K | <0.1% | +23,707 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −94,000−100.0% | Sold out | Holders |
| Q1 2023 | 94,000 | $1.75M | <0.1% | +94,000 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −35,500−100.0% | Sold out | Holders |
| Q3 2022 | 35,500 | $420.0K | <0.1% | −20,100−36.2% | Reduced | Holders |
| Q2 2022 | 55,600 | $734.0K | <0.1% | +36,800+195.7% | Added | Holders |
| Q1 2022 | 18,800 | $393.0K | <0.1% | +18,800 | New | Holders |